## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a
Psychometric attributes of the rating scale for gait evaluation in Parkinson's disease
✍ Scribed by Marcos Serrano-Dueñas; Belén Calero; Soledad Serrano; Maite Serrano; Paulina Coronel
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 82 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background:
The RSGE‐PD‐V2.0 is a specific measure for evaluation of gait impairment in PD.
Objective:
To check the RSGE‐PD‐V2.0 metrics attributes.
Methods:
In addition to demographic and historical data of PD, applied assessments were: Hoehn and Yahr staging (H&Y); impact in daily activities with Schwab and England scale (S&E); SCOPA Motor; mental status with Short portable mental status questionnaire (SPMSQ); quality of life with Parkinson's impact scale (PIMS), the Hamilton Depression Rating Scale‐6 items (HDRS‐6); and, the Clinical Impression of Severity Index‐PD (CISI‐PD).
Results:
151 PD patients were included (n = 102 (67.5%) were male). Most patients were in H&Y stage 3 (n = 78 (51.6%)). Mean of age and duration of disease was 68.4 and 7.6 years respectively. Mean values of L‐Dopa doses was 652.6 mg/day. Mean values of SCOPA Motor were 29.1; SPMSQ: 1.8; HADS‐6: 9.2; PIMS: 18.7;RSGE‐PD‐V2.0: 25.4; and, CISI‐PD were 10.8. Full computable scores were 100%; Guttman's lambda, 0.954; and the item‐total correlation, 0.408‐0.830. Correlation coefficients (Spearman's rho) between RSGE‐PD‐V2.0 and H&Y, S&E, SCOPA Motor, PIMS and CISI‐PD, were: 0.62; ‐0.75; 0.74; 0.46; and, 0.78 respectively. RSGE‐PD‐V2.0 scale significantly discriminated among PD severity levels (based on H&Y staging) Kruskal‐Wallis (p < 0.000).
Conclusions:
Metric attributes of the RSGE‐PD‐V2.0 in this sample of study resulted in has sufficient and suitable satisfactory. We, therefore, believe that RSGE‐PD‐V2.0 is easy and a useful and recommendable specific tool for measuring gait disease in PD patients. © 2010 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The Hospital Anxiety and Depression Scale (HADS) has been used in Parkinson's disease (PD) but information about its psychometric properties in this context is limited. The aim of this study is to assess the psychometric properties of the HADS in PD. In an observational, cross‐sectional
## Abstract We assessed the clinometric characteristics of rating scales used for the evaluation of motor impairment and disability of patients with Parkinson's disease (PD), conducting a systematic review of PD rating scales published from 1960 to the present. Thirty studies describing clinometric
## Abstract Apathy is a unique, multidimensional syndrome commonly encountered in patients with Parkinson disease (PD). Recently, the Lille Apathy Rating Scale (LARS), a semistructured interview yielding a global score, and composite subscores for different domains of apathy (i.e., cognitive, behav
## Abstract This study assessed the psychometric attributes of the modified Parkinson Psychosis Rating Scale (mPPRS). In an attempt to improve scale's scaling assumptions and content validity, all types of hallucinations were rated and all items were scored based on intensity. The scale was cross‐c
We developed a teaching tape of the motor section of the Unified Parkinson's Disease Rating Scale (UPDRS) to provide investigators with a visual document of three raters' interpretations of the scoring system for each item except rigidity. The rate of agreement for the selected samples was always si